annb0t
Top 20
Mesoblast Limited
NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the second quarter ended December 31, 2021.
The webcast will begin at 5.00pm EST, Thursday, February 24; 9.00am AEDT, Friday, February 25, 2022. It can be accessed via: https://webcast.openbriefing.com/8499/
The archived webcast will be av...
>>> Read more: Mesoblast Corporate Update and Financial Results Webcast
NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the second quarter ended December 31, 2021.
The webcast will begin at 5.00pm EST, Thursday, February 24; 9.00am AEDT, Friday, February 25, 2022. It can be accessed via: https://webcast.openbriefing.com/8499/
The archived webcast will be av...
>>> Read more: Mesoblast Corporate Update and Financial Results Webcast
